Bligh and Dyer, (1959, “A rapid method of total lipid extraction and purification,” Can J. Biochem. Physiol. 37(8):911-917. |
Blusztajn, J.K., et al, “Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients,” Brain Research, 536 (1990) 240-244. |
Dorum et al., (1996), “Early detection of familial ovarian cancer,” E. J. Cancer 32A (10): 1645-1651. |
Einhorn et al., (1992), “Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer,” Obstet. Gynecol. 80:14-18. |
Fallbrook A., et al, “Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity,” Brain Research 834, (1999) 207-210. |
Fukami, et al., (1988), “Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis,” Proc. Natl. Acad. Sci. USA 85:9057-9061. |
Gregor Devc, ed., Phospholipids Handbook, Ch. 28: Gupta, “Phospholipids in Disease,” pp. 895-908, 1993. |
Holmes, Todd C., et al. “Phospholipid and Phospholipid Metabolites in Rat Frontal Cortex Are Decreased following Nucleus Basalis Lesions,” Ann. NY Acad. Sci. 1993, 695:241-3. |
Jacobs et al., (1996), “Risk of diagnosis of ovarian cancer after raised serum CA 12s concentration: a prospective cohort study,” BMJ 313:1355-1358. |
Jalink et al., (1994), “Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator,” Biochim. Biophys. Acta 1198:185-196. |
Kalnova (1989), “Relationship between antioxidant activity and lipid profile of blood as marker of the effect of tumor on the host,” Vopr. Onkol 35(7):795-801 abstract only. |
Kriat et al., (1993), “Analysis of plasma lipids by NMR spectroscopy: Application to modifications induced by malignant tumors,” J. Lipid res. 34:1009-1019. |
Kume and Gimbrone, (1994), “Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells,” J. Clin. Invest. 93:907-911. |
Lloret and Moreno, (1995), “Ca2+ Influx, Phosphoinositide Hydrolysis, and Histamine Release Induced by Lysophosphatidylserine in Mast Cells,” J. Cell Physiol. 165:89-95. |
Mills et al., (1988), “A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action,” Cancer Research 48:1066-1071. |
Mills et al., (1990), “Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells,” J. Clin. Invest. 86:851-855. |
Moolenaar, (1995), “Lysophosphatidic acid signalling,” Current Opinion in Cell. Biol. 7:203-210. |
Moolenaar, (1995), “Lysophosphatidic acid, a multifunctional phospholipid messenger,” J. Biol. Chem. 270(22):12949-12951. |
Moolenaar et al, (1992), “Lysophosphatidic acid: A bioactive phospholipid with growth factor-like properties,” Rev. Physiol. Biochem. Pharmacol. 119:47-65. |
Muto et al., (1993), “Screening for Ovarian Cancer: The preliminary experience of a familiar ovarian cancer center,” Gynecologic Oncol. 51:12-20. |
Nakano et al., (1994), “Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes,” Proc. Natl. Acad. Sci. USA 91:1069-1073. |
Nitsch, R.M., et al. “Evidence for a membrane defect in Alzheimer disease brain,” Proc. Natl. Acad. Sci. USA, vol. 89, pp 1671-1675, Mar. 1992. |
Nitsch, R.M., et al. “Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy,” Neuroscience Letters, 161 (1993) 191-194. |
Okita et al., (19997), “Elevated Levels and altered fatty acid compositon of plasma lysophosphatidylcholine (LYSOPC) in ovarian cancer patients,” Int. J. Cancer 71:31-34. |
Panetti et al., (1997), “Endothelial cell mitogenesis induced by LPA: Inhibiton by thrombospondin-1 and thrombospondin-2,” J. Lab. Clin. Med. 129:208-216. |
Phillips and Dodge, (1967), “Composition of phospholipids and of phospholipid fatty acids of human plasma,” J. Lipid Res. 8: 676-681. |
Podo, Franco, “Nuclear Magnetic Resonance Analysis of Tumor Necrosis Factor-induced Alterations of Phospholipid Metabolites and pH in Friend Leukemia Cell Tumors and Fibrosarcomas in Mice.” Cancer Research, 47, 6481-6489, Dec. 15, 1987. |
Racenis et a., (1992), “The Acyl Dihydroxyacetone Phosphate Pathway Enzymes for Glycerolipid Biosynthesis are Present in the Yeast Saccharomyces cerevisiae, ” J. Bacteriol. 174:5702-5710. |
Sasaki et al., (1993), “Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids,” FEBS Letters 310(1):47-51. |
Schapira et al., (1993), “The effectiveness of ovarian cancer screening: A decision analysis model,” Ann. Intern. Med. 118:838-843. |
Shen et al., (1997), “Evaluation of lysophosphatidic acid (LPA) as a diagnostic marker for ovarian cancer and other gynecological cancers,” Clinical Chemistry 43(6):577. |
Skipski et al., (1967, “Lipid composition of human serum lipoproteins,” Biochem. J. 104:340-352. |
Tamori-Natori et al., (1986), “Metabolism of Lysophosphatidylserine, a Potentiator of Histamine Release in rat Mast Cells,” J. Biochem. (Tokyo) 100(3):581-590. |
Thomas and Holub, (1991), Eicosanoid-dependent and -independent formation of individual [14C]stearoyl-labeled lysophospholipids in collage-stimulated human platelets,: Biochim. Biophys. Acta 1081:92-98. |
Tigyi et al., 1994, Lysophosphatidic acid possesses dual action in cell proliferation,: Proc. Natl. Acad. Sci. USA 91:1908-1912. |
Tokumura et al., 1986, “Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma,” Biochim. Biophys. Acta 875:31-38. |
Van den Bosch et al., 1974, “Phosphoglyceride Metabolism,” Ann. Rev. Biochem. 43:243-277. |
Vogt, 1960, “Darmerregende Aktivtät verschiedener Phosphatide und Glykolipide,” Arch exp. Path. U. Pharmak. 240:134-139. |
Xu et al., (1995), “Lysophospholipids activate ovarian and breast cancer cells,” Biochem J. 309:933-940. |
Xu et al., (1995), “Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients1,” Clin. Cancer Res. 1:1123-1232. |
Xu et al., (1995), “Effect of Lysophospholipids on Signaling in the Human Jurkat T Cell Line,” J. Cell Physiol 163: 441-450. |
Zhou, Jianhui et al., “Identification of the First Mammalian Sphingosine Phosphate Lyase Gene and Its Functional Expression in Yeast,” Biomedical and Biophysical Research Communications, 242, 502-507 (1998) Article No. RC977993. |